Two Sigma Advisers
OMIC

Two Sigma Advisers’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Two Sigma Advisers’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-770
Closed -$28K – 2724
2023
Q1 		$28K Sell
770
-373
-33% -$22.9K ﹤0.01% 2497
2022
Q4 		$68.9K Sell
1,143
-357
-24% -$23.9K ﹤0.01% 2334
2022
Q3 		$113K Sell
1,500
-1,077
-42% -$113K ﹤0.01% 2294
2022
Q2 		$295K Buy
+2,577
New +$302K ﹤0.01% 2129

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Two Sigma Advisers's OMIC Position: Q2 2023 in Review

Two Sigma Advisers sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q2 2023, closing a stake of 770 shares — an estimated $28K sold.

Two Sigma Advisers first reported a position in OMIC in Q2 2022 and held it in 4 quarters. The position peaked at $295K in Q2 2022. 62 funds tracked by Wall St. Rank hold OMIC as of Q2 2023.

  • Two Sigma Advisers reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Two Sigma Advisers sold 770 Singular Genomics Systems, Inc. Common Stock shares in Q2 2023, an estimated $28K.
  • Two Sigma Advisers first reported a position in Singular Genomics Systems, Inc. Common Stock in Q2 2022 and held it in 4 quarters.
  • Two Sigma Advisers's Singular Genomics Systems, Inc. Common Stock position peaked at $295K in Q2 2022.
  • 62 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q2 2023.

Based on Two Sigma Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.